TOBRAMYCIN AND DEXAMETHASONE

N/A

Manufactured by Novartis Pharmaceuticals Corporation

6,884 FDA adverse event reports analyzed

Last updated: 2026-04-15

About TOBRAMYCIN AND DEXAMETHASONE

TOBRAMYCIN AND DEXAMETHASONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Novartis Pharmaceuticals Corporation. The most commonly reported adverse reactions for TOBRAMYCIN AND DEXAMETHASONE include EYE PAIN, OFF LABEL USE, DRUG INEFFECTIVE, HEADACHE, VISION BLURRED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TOBRAMYCIN AND DEXAMETHASONE.

Top Adverse Reactions

EYE PAIN230 reports
OFF LABEL USE206 reports
DRUG INEFFECTIVE170 reports
HEADACHE170 reports
VISION BLURRED168 reports
OCULAR HYPERAEMIA165 reports
EYE IRRITATION158 reports
NAUSEA157 reports
FATIGUE155 reports
PAIN135 reports
DIZZINESS133 reports
DIARRHOEA127 reports
DYSPNOEA119 reports
VISUAL IMPAIRMENT114 reports
ANXIETY103 reports
RASH99 reports
HYPERSENSITIVITY92 reports
CATARACT88 reports
INTRAOCULAR PRESSURE INCREASED88 reports
EYE SWELLING86 reports
ASTHENIA82 reports
CONDITION AGGRAVATED82 reports
CHRONIC KIDNEY DISEASE80 reports
PNEUMONIA80 reports
WEIGHT DECREASED78 reports
LACRIMATION INCREASED77 reports
PHOTOPHOBIA76 reports
FALL75 reports
VISUAL ACUITY REDUCED75 reports
ENDOPHTHALMITIS74 reports
PYREXIA73 reports
CONJUNCTIVITIS72 reports
CONSTIPATION72 reports
VOMITING72 reports
DRY EYE69 reports
PRURITUS69 reports
BACK PAIN66 reports
ERYTHEMA65 reports
RENAL FAILURE64 reports
DEPRESSION63 reports
COUGH61 reports
EYE PRURITUS61 reports
CONJUNCTIVAL HYPERAEMIA59 reports
MUSCLE SPASMS59 reports
PAIN IN EXTREMITY59 reports
MALAISE58 reports
PRODUCT DOSE OMISSION ISSUE56 reports
ARTHRALGIA55 reports
EYE DISORDER55 reports
HYPERTENSION55 reports
BLOOD PRESSURE INCREASED52 reports
EMOTIONAL DISTRESS52 reports
UVEITIS52 reports
TINNITUS51 reports
DEATH50 reports
PRODUCT USE IN UNAPPROVED INDICATION50 reports
ACUTE KIDNEY INJURY48 reports
ALOPECIA48 reports
RETINAL DETACHMENT48 reports
CHEST PAIN47 reports
DECREASED APPETITE47 reports
DRUG HYPERSENSITIVITY47 reports
GASTROOESOPHAGEAL REFLUX DISEASE47 reports
EYE INFECTION46 reports
GAIT DISTURBANCE46 reports
GLAUCOMA46 reports
INSOMNIA46 reports
ABDOMINAL PAIN44 reports
FOREIGN BODY SENSATION IN EYES43 reports
INFLAMMATION43 reports
PALPITATIONS43 reports
CORNEAL OEDEMA42 reports
DYSPHAGIA42 reports
INJURY42 reports
OCULAR HYPERTENSION41 reports
SINUSITIS41 reports
RETINOPATHY40 reports
TOXIC ANTERIOR SEGMENT SYNDROME40 reports
ABDOMINAL DISCOMFORT39 reports
ANAEMIA39 reports
COVID 1939 reports
HYPOTENSION39 reports
PRODUCT QUALITY ISSUE39 reports
URINARY TRACT INFECTION39 reports
ABDOMINAL PAIN UPPER38 reports
FEELING ABNORMAL38 reports
CEREBROVASCULAR ACCIDENT37 reports
MUSCULAR WEAKNESS37 reports
EYE INFLAMMATION36 reports
OCULAR DISCOMFORT36 reports
MYOCARDIAL INFARCTION35 reports
ULCERATIVE KERATITIS35 reports
VITRITIS35 reports
ABDOMINAL DISTENSION34 reports
BLINDNESS34 reports
OSTEOPENIA34 reports
PERIPHERAL SWELLING34 reports
EYE DISCHARGE33 reports
PRODUCT USE ISSUE33 reports
DEHYDRATION32 reports

Report Outcomes

Out of 3,126 classified reports for TOBRAMYCIN AND DEXAMETHASONE:

Serious 68.5%Non-Serious 31.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,837 (63.4%)
Male1,051 (36.3%)
Unknown10 (0.3%)

Reports by Age

Age 7559 reports
Age 7756 reports
Age 7053 reports
Age 7851 reports
Age 6848 reports
Age 4847 reports
Age 5747 reports
Age 5546 reports
Age 7946 reports
Age 7245 reports
Age 7645 reports
Age 6044 reports
Age 6644 reports
Age 6944 reports
Age 7341 reports
Age 6240 reports
Age 6540 reports
Age 7440 reports
Age 7139 reports
Age 4938 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TOBRAMYCIN AND DEXAMETHASONE?

This profile reflects 6,884 FDA FAERS reports that mention TOBRAMYCIN AND DEXAMETHASONE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TOBRAMYCIN AND DEXAMETHASONE?

Frequently reported terms in FAERS include EYE PAIN, OFF LABEL USE, DRUG INEFFECTIVE, HEADACHE, VISION BLURRED, OCULAR HYPERAEMIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TOBRAMYCIN AND DEXAMETHASONE?

Labeling and FAERS entries often list Novartis Pharmaceuticals Corporation in connection with TOBRAMYCIN AND DEXAMETHASONE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.